coronavirus vaccine will be needed.Chief Financial Officer Joseph Wolk said that the health-care behemoth is currently in talks with the European Union, Japan and the Bill & Melinda Gates Foundation about locking up supply of the vaccine candidate.“We’re still trying to determine the volumes," he said in an interview.J&J, which received a $456 million award from the Biomedical Advanced Research and Development Authority, will work with the US and other countries and organizations to determine a “universal, global price" based on its manufacturing costs, as well as research and development expenses.
BARDA is the US agency responsible for developing medical countermeasures to emergencies.Expenses will be “almost a 50-50 split" between R&D and.